BIO (Biotech Innovation Organization) collected a survey in January of 2020 to better understand the current demographics of biopharma companies. Responses to their questions on representation indicate that the number of women decreases at higher levels. They found...
If you are raising capital now, the path you are about to embark on can be stressful and littered with obstacles, but the light at the end of the tunnel is worth the trials and tribulations. Despite the inherent challenges of fundraising, the current climate is quite...
Term sheet negotiations are rarely easy, and there are multiple ways negotiations can break down before a deal is reached. Like many things in the biopharma industry, a big success factor in successful term sheet negotiations is effective communication. Below are some...
Every entrepreneur hopes that if they build it, someday someone will come knocking at their door with a large check. But what does it take to get someone to knock on that door? And, how do you make sure your caller actually has a large check? Selling. Companies are...
The cornerstone to a successful negotiation is strong internal alignment on the objectives and structure for a deal. More often than not, companies will enter into a negotiation process in a reactionary position and gloss over, or skip entirely, the internal...
The classic adage teaches that it is better to have a certain, but perhaps lesser than expected, outcome than the possibility of something greater that may never come. This lesson holds true for dealing with biopharma transactions. The difficulty of managing an offer...